Colon Pharmaceuticals announced that on July 9, 2026, the relevant state departments issued the “National Essential Drug Catalogue”. A total of 157 main products sold by the company and its holding subsidiaries were included in the catalogue. A total of 35 products have been added. The products include various types of products such as engliflozin tablets, etripopa ethanolamine tablets, and olapalil tablets. The new catalogue will be implemented on September 1, 2026, which is conducive to the promotion and use of related products in medical institutions at all levels.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.